Vir Biotechnology's GAAP loss for 2021 was $528.584 million, up 77% from $298.665 million in the previous year. Revenue increased 14.4 times to $1.095 billion from $0.076 billion a year earlier.
Vir Biotechnology's GAAP loss for 2021 was $528.584 million, up 77% from $298.665 million in the previous year. Revenue increased 14.4 times to $1.095 billion from $0.076 billion a year earlier. 
investors.vir.bio
English (US) 